Highlights
Amarex Taiwan, LLC began as a concept in 2003, after several years of steady growth of services provided by Amarex Clinical Research (USA) to Taiwanese companies, Amarex Taiwan has established and worked closely with Amarex Clinical Research (USA) to better serve Asia-Pacific clients.
Amarex Taiwan provide services including manage clinical sites, safety monitoring, and regulatory compliance for Phase I – III clinical trials that have sites in Taiwan. Amarex Taiwan works closely with Amarex Clinical Research (USA) who provides regulatory affairs services and all other clinical trial support services such as protocol writing, data management, data analysis, and clinical study report writing.
Amarex’s vision and goals make Amarex different from other CROs:
- Commit to a long-term client relationship and achieving the best possible outcome
- Believe in having a true collaborative partnership with our clients
- Very experienced leadership team members and staff
- Optimize time and cost while maintaining high quality of service
| Disease Area/ Indication |
Name of Trial |
| Antiseptic |
11 |
| Cardiovascular |
29 |
| CNS |
49 |
| Dermatology |
3 |
| GI |
17 |
| Hematology |
14 |
| Infectious Disease |
64 |
| Endocrine, Metabolic, Diabetes |
22 |
| Oncology |
35 |
| Orthopedic |
5 |
| Pain Management |
23 |
| Respiratory |
4 |
| Rheumatology |
4 |
| Urology |
17 |
| Vaccine |
23 |
| Wound Healing |
54 |
Services
-
Taiwan and Global Clinical Trials Phase I-IV, Project Management, Protocol Writing, Study Feasibility, Biostatistics, Data Management, Pharmacovigilance
-
Regulatory Services Product development strategies; IND, IDE, 510K applications; FDA meetings; Marketing Approval applications; Integrated Summaries of Safety and Efficacy.
-
Medical Writing Protocol, Clinical Study Report (CSR), Informed Consent Form, Investigator’s Brochure
-
Audits GMP, GCP, GLP regulatory compliance audits
